New research comparing different approaches to dementia care for people with Alzheimer’s disease and other dementias found no significant differences in patient behavioral symptoms or caregiver strain, whether delivered through a health system, provided by a community-based organization, or as usual care over an 18-month period.
Incyte says JAK cream clears PhIII eczema trial in children, but analysts are still watching safety
On a long march to bring its topical JAK inhibitor to the blockbuster ranks, Incyte is celebrating positive results from a Phase III trial involving
July 13, 2023